Francesca Porcellati

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Tirzepatide for Excess Weight in Adults With Type 1 Diabetes Using MiniMed 780G.

Tirzepatide for Excess Weight in Adults With Type 1 Diabetes Using MiniMed 780G.

Journal: Diabetes, obesity & metabolism

Published: April 04, 2026

Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.

Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.

Journal: The lancet. Diabetes & endocrinology

Published: March 04, 2026

GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology.

GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology.

Journal: Diabetes, obesity & metabolism

Published: March 03, 2026

The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes Mellitus.

The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes Mellitus.

Journal: Diabetes, obesity & metabolism

Published: January 31, 2026

Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review.

Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review.

Journal: Nutrients

Published: November 05, 2025

The Sweet Side of Constipation: Colonic Motor Dysfunction in Diabetes Mellitus.

The Sweet Side of Constipation: Colonic Motor Dysfunction in Diabetes Mellitus.

Journal: Nutrients

Published: August 26, 2025

An overview of randomized clinical trials of fixed-ratio combinations of basal insulin plus GLP-1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes.

An overview of randomized clinical trials of fixed-ratio combinations of basal insulin plus GLP-1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: May 04, 2025

Switching from insulin injections to degludec/liraglutide in older frail persons: 6-month body composition remodelling.

Switching from insulin injections to degludec/liraglutide in older frail persons: 6-month body composition remodelling.

Journal: European geriatric medicine

Published: April 19, 2025

The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study.

The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study.

Journal: Diabetes research and clinical practice

Published: January 26, 2025

A new role for glucagon: from secondary hormone to key player.

A new role for glucagon: from secondary hormone to key player.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: December 15, 2024

The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes.

The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes.

Journal: Diabetes care

Published: December 10, 2024

Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.

Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.

Journal: International journal of molecular sciences

Published: February 29, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026